Testing effectiveness (Phase 2)Active Not RecruitingNCT04397003
What this trial is testing
Personalized Neoantigen Vaccine in Combination With Durvalumab (MEDI4736) in Extensive Stage Small Cell Lung Cancer
Who this might be right for
Extensive-stage Small Cell Lung Cancer
Washington University School of Medicine 6